TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: pneumonia with the need for antibiotic treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Assisting Hand Assessment (AHA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of LMA insertion attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final LMA insertion time taken duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal fasting glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Grading of Skin Aging and Photodamage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Serum high sensitivity C reactive protein (hsCRP) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of clean
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of compliant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of pass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Japanese Orthopaedics Association (mJOA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in nurses PCC competency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in Polyp Detection Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Comfortable procedure endorsement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recurrent Caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight Gain Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length Growth Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Head Circumference Growth Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patient reported treatment burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse events of SAIL66
Endpoint domain: Adverse events/effects
Primary endpoint: Preliminary anti-tumor activity of SAIL66
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from Baseline in Evaluation Of Coping Attitudes (COPE)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Size of defect covered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance to infection
Endpoint domain: Adverse events/effects
Primary endpoint: DLT after CT071 infusion
Endpoint domain: Adverse events/effects
Primary endpoint: AE of Neurotoxicity and cytokine release syndrome after CT071 infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Change of frequency and intensity of nightmares
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tinetti balance and walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measuring peripheral muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional independence scale (FIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Skinfold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength 5-repetition max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Number of Days of Alcohol Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Number of Days of Heavy Alcohol Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Number of Days of Marijuana Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Number of Days of Opioid Drug Misuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Segment girth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cut off value strain ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum value of Young's modulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aspirin resistance prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Referred pain area after suprathreshold pressure stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Altered range of motion of the hamstring muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: CD T cell changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Buccal Soft Tissue Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in SALT Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nighttime systolic BP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Absolute oral bioavailability (F [%]) of GLPG3970
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of total radioactivity excreted in urine expressed as a percentage of the administered dose (Ae%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of total radioactivity excreted in feces expressed as a percentage of the administered dose (Ae%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motion Perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients achieving acyclovir minimum plasma concentration of 0.5 mg/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Solicited Symptoms of Reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Serious Adverse Events (SAEs) and Medically Attended Adverse Events (MAAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of orofacial pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Location of orofacial pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of orofacial pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PACU Delirium
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Intraoperative oculocardiac reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Who Experience Anaphylactic Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Experience Thromboembolism
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Experience Aseptic Meningitis
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in peripheral pulse volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Child weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Genomic testing results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral testing results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolomic testing results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corticolimbic network resting-state functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and types of encounters
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diagnoses addressed in encounters
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Services provided
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: clinical cure rate of BV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of IV Favipiravir
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Survivors who participate
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants Completing Intervention Sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in percentage of participant satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IL-8 Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adherence Rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Attrition Rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean percent reduction in CPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of all-cause mortality and allograft-related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy of Tacrolimus Inhalation Powder in preventing acute rejection events
Endpoint domain: Physiological/clinical
Primary endpoint: Development of overt hepatic encephalopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Visual Analog Scale (VAS) pain at first steps in the morning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) worst pain of the day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of venous congestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Star Cancellation Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Line Bisection Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Activities Scale for Kids - performance version (ASKp) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in ADHD symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAD response rate (PR or CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-Free Rate at 4 months
Endpoint domain: Mortality/survival
Primary endpoint: Completion of transabdominal ISR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Cardiac Troponin T (cTNT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Creatinine kinase-MB (CK-MB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spasticity lower extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in COPD health status as assessed by the COPD assessment test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in COPD health status/health-related quality of life as assessed by the Clinical COPD Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Attitude towards reporting child abuse and neglect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knowledge of trauma sensitive treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behaviour in detecting and reporting child abuse
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change-from-baseline QTc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the Mean FSS Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Body composition - BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rehospitalization rates associated with exacerbation of pulmonary arterial hypertension
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to first event of major adverse cardiac events (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Completion rate of the sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Complete Response at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 2 or Higher Non-Haematologic Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Mean velocity at different %1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak velocity at different %1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CIRUS-RBD Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Power output generated in 1 set at 65%1RM until task failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choice Delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibitory Control (Go/No-Go)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in insulin resistance (M value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Retention in Methadone Treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pediatric anesthesia of emergence delirium (PAED) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constipation symptom improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in exodeviation control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue state
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Global recovery scoring system (patient satisfaction scale)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: amount of radiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year event free survival (EFS)
Endpoint domain: Mortality/survival
Primary endpoint: Drug effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual outcome of the scar
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Achalasia symptom questionnaire (ASQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Short form (SF)-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of ventilator-free days (VFDs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Central Line Associated Bloodstream Infection (CLABSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of transferrin saturation in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Daily changes of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily changes of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily changes of distress tolerance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: VAS pain score - chair rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound elastography measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of 1-lead ECG interpretation for cardiac arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Completion of Advance Directives
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in concordance of end of life (EOL) Attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in experience of end of life issues
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medication Administration Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of Early Allograft Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline skin appearance (Edemas, blisters, bubbles, scars, erythema)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from baseline skin sensation (itching, tingling, burning sensations)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Post treatment pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Falls detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of confidence in understanding costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Recovery percentage of peripheral blood lymphocyte subsets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Deterioration percentage of peripheral blood pro-inflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in pronunciation effect
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effective diuresis at 6 hours post intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of fundus neovascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area of fundus neovascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Intensity of neovascularization fluorescein leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Geometric Mean Titer (GMT) of anti-omicron neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 4-fold rise rate of anti-omicron neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in foot circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pitting edema grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood pressure systolic and diastolic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sino-Nasal Outcome Test (SNOT-22) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CSI pVAD System device placement/procedural success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of severe hypotension while on CSI pVAD device support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in participant subjective emotional ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Fear Circuit Blood Oxygen Level-Dependent (BOLD) Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Toxicity of the treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Confusion Assessment Method (CAM- ICU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Montreal Cognitive Assessment (MoCA- Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MMSE (Minimental State Examination)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total radioactivity in urine and faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint Position Error Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cervical Joint Range of Motion Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Habitual sleep duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleep behaviors
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Malawi Developmental Assessment Tool (MDAT) global z-score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Adapted Patient Health Questionnaire-9 (PHQ-9) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recruitment and retention feasibility
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of mandibular fibula free flap reconstruction
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Rest-to-exercise change in DLNO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gas exchange outcomes
Primary endpoint: Rest-to-exercise change in DLCOc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gas exchange outcomes
Primary endpoint: Rest-to-exercise change in DM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gas exchange outcomes
Primary endpoint: Oxygenation as Measured by P:F Ratio (PaO2:FiO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle fascicle length and muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes